Materialise engineers coordinated the development of a surgical plan and created an on-screen 3D model based on CT-scans.
During a preparation period of 14 months, Materialise clinical engineers formed a cohesive team alongside NYU Langone surgeons, rehearsing the operation in a lab environment to develop and fine-tune the surgical plan.
Image-based planning and medical 3D printing have completely revolutionized personalized patient care by providing surgeons with detailed insights and an additional level of confidence before entering the operation room.
During a preparation period of 14 months, Materialise clinical engineers formed a cohesive team alongside NYU Langone surgeons, rehearsing the operation in a lab environment to develop and fine-tune the surgical plan.
Pre-surgical planning made it possible for surgeons to virtually select and position various medical implants to predict the optimal anatomical fit.
A fully guided system for bone fragment repositioning and fixation was unique to the patient’s anatomy and helped position the medical tools with great precision, reducing the overall surgery time.

Three-dimensional technologies, developed by Materialise, played a crucial role in the world’s first simultaneous double hand and face transplant that was successfully performed at NYU Langone Health in Manhattan. Materialise’s innovative 3-D planning and printing tools enable the speed and accuracy required for such a complex medical procedure.

February 3, 2021 — A study led by UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine shows that Black children are 18% less likely to get imaging tests as part of their emergency department visit compared to White children. Hispanic children are 13% less likely to have imaging done than Whites.

February 3, 2021 — Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry receptors for estrogen. But the therapy only works for about half of all patients. Until now, there hasn't been a good way to reliably predict who will benefit and who will not.

February 2, 2021 — In response to the lockdown and social distancing measures enacted to combat the spread of COVID-19, healthcare providers have increasingly adopted the use of remote technologies.

February 2, 2021 — Volpara Health, a health technology software company whose integrated breast care platform assists in the delivery of personalized patient care, announced the acquisition of CRA Health, LLC, a breast cancer risk assessment company spinoff from Massachusetts General Hospital — a Harvard Medical School teaching hospital.

February 1, 2021 — Canon Medical is bringing the power of accessible artificial intelligence (AI) for improved image quality to more patients with expanded clinical indications for 1.5T MR.

February 1, 2021 — COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.

February 1, 2021 — Researchers at the Beckman Institute for Advanced Science and Technology were part of a collaborative effort to investigate a new strategy to manage sodium levels in patients with kidney failure who were undergoing hemodialysis treatment.

January 29, 2021 — A nationwide panel of experts has developed the first mammography guidelines for older survivors of breast cancer, providing a framework for discussions between survivors and their physicians on the pros and cons of screening in survivors' later years.

January 29, 2021 — Fuzionaire Radioisotope Technologies K.K. (“FRIT”) announced that it has entered into a feasibility study agreement with Nihon Medi-Physics Co., Ltd. (“NMP”), a leading radiopharmaceutical company in Japan, engaged in R&D, manufacturing, and distribution.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now